Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biohaven Ltd (BHVN)

Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Biohaven Stock Dove by Nearly 20% on Thursday

NFLX : 1,261.95 (+1.35%)
BHVN : 14.19 (+1.87%)
$SPX : 6,268.56 (+0.14%)
Why BioHaven Stock Is Soaring Today

Shares of Biohaven (NYSE: BHVN) are surging on Monday. The company's stock was up about 8% as of midday trading and had climbed as much as 10% earlier in the day. The move comes as the S&P 500 traded mixed...

COMP : 6.67 (+2.14%)
NFLX : 1,261.95 (+1.35%)
BHVN : 14.19 (+1.87%)
Why Biohaven Stock Plummeted by More Than 15% Today

On Friday's news that Biohaven (NYSE: BHVN) withdrew its application for a top investigational drug from an important regulator, investors aggressively traded out of the stock. The clinical-stage biotech...

NFLX : 1,261.95 (+1.35%)
BHVN : 14.19 (+1.87%)
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

Shares of early-stage biotech stocks, including Biohaven (NYSE: BHVN), Recursion Pharmaceuticals (NASDAQ: RXRX) , and CRISPR Therapeutics (NASDAQ: CRSP) , plunged in March, with the stocks down 35.3%,...

BHVN : 14.19 (+1.87%)
CRSP : 56.42 (-0.67%)
RXRX : 5.28 (unch)
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

BHVN : 14.19 (+1.87%)
COLL : 32.83 (+0.95%)
TRVI : 7.01 (+7.02%)
AVTX : 4.90 (+2.51%)
Company News for Mar 4, 2025

California Resources Corp.’s (CRC) shares plummeted 11.7% after posting fourth-quarter 2024 adjusted earnings per share of $0.91, missing the Zacks Consensus Estimate of $0.34.Shares of TG Therapeutics...

TGTX : 38.92 (+4.95%)
BHVN : 14.19 (+1.87%)
CRC : 47.60 (-0.52%)
NOMD : 17.33 (-1.25%)
Why Biohaven Stock Triumphed on Tuesday

News of a big and important regulator's move was the electricity that powered Biohaven (NYSE: BHVN) stock to an 11%-plus gain on the second trading day of the week. Its leading investigational drug is...

BHVN : 14.19 (+1.87%)
Biohaven Stock Surges After Director Acquires Shares Worth Over $1M: Retail Sentiment Turns Bullish

Earlier this month, Biohaven reported achieving important milestones in the trial of its experimental drug BHV-1300, which is intended for use in the treatment of kidney disease.

BHVN : 14.19 (+1.87%)
Biohaven’s SMA Trial Miss Bolsters Scholar Rock Stock: Analysts Give Verdicts, Retail Watches Closely

Last month, Scholar Rock achieved the primary endpoint in the company's own Phase 3 trial of apitegromab in SMA patients.

BHVN : 14.19 (+1.87%)
VTI : 307.72 (+0.23%)
SRRK : 38.59 (+3.07%)
IWM : 223.19 (+0.67%)
XBI : 88.27 (+1.44%)
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal

Shares of Scholar Rock SRRK skyrocketed 362% on Monday after the company announced positive top-line results from the late-stage study, evaluating the efficacy and safety of its investigational muscle-targeted...

BHVN : 14.19 (+1.87%)
ANIP : 65.19 (+0.35%)
CPRX : 21.62 (-0.87%)
SRRK : 38.59 (+3.07%)

Barchart Exclusives

Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?
Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to $27. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar